Future studies focusing on the incidence of lung cancers and better addressing causal questions are therefore needed. Strengths of this study include the prospective design, large sample size and validated endpoints. Limitations include the fact that this cohort recruited people in three cities in ...
Most people think oflung canceras an older person's disease, but it also affects young people. Lung cancer is less common among young people, and the risk factors andtypes of lung cancerare different than for older adults. Lung cancer in young adults requires comprehensive and early treatment,...
Lung cancer, the malignant transformation of lung tissue, is the leading cause of cancer-related deaths.
Lung Cancer Leukemia By Robert Peter Gale, MD, PhD, DSc (hc), FACP, FRCP, FRCPI (hon), FRSM/May 10, 2025 Therapy With a Tyrosine Kinase Inhibitor for EGFR-Variant Lung Adenocarcinoma: Lessons From Chronic Myeloid Leukemia? There has been remarkable progress in treating EGFR-variant lung ad...
EMRELIS is a prescription medicine used to treat adults with non-squamous non-small cell lung cancer (NSCLC): that has spread to areas near the lungs (locally advanced) or to other parts of the body (metastatic), a...
Dr. Wiener emphasizes the need to avoid the hard lessons learned from the "overzealous implementation" of prostate cancer screening. It is imperative to get the implementation of LDCT screening for Medicare beneficiaries "right from the outset," she writes. ...
Gavreto is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic), and is caused by abnormal rearranged during... Is Shingles Contagious? Shingles is an infection caused by the varicella-zoster virus. Shingl...
In addition to EGFR, other genetic mutations driving lung cancer that researchers are beginning to unravel include ALK, ROS1 and BRAF. This new information is guiding the development of advanced treatments that are significantly extending life expectancy for some patients. “The field by and large ...
Younger patients with lung cancer are significantly more likely than older patients to be diagnosed with later stages of disease, illustrating the need to develop strategies to increase the early detection of lung cancer among younger patients who are cu
All Rights Reserved.More from CBS News Biden's prostate cancer diagnosis raises questions about screening What to know about Biden's prostate cancer diagnosis Housing, nutrition in peril as Trump pulls back Medicaid social services How to limit exposure to arsenic in rice ...